The Net Margin of Shin Nippon Biomedical Laboratories Ltd (2395.T) is 15.19%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-03-31 | 15.19% |
| 2024-03-31 | 20.91% |
| 2023-03-31 | 24.15% |
| 2022-03-31 | 40.16% |
| 2021-03-31 | 24.23% |
| 2020-03-31 | 17.52% |
| 2019-03-31 | 12.46% |
| 2018-03-31 | -21.42% |
| 2017-03-31 | -5.31% |
| 2016-03-31 | 17.94% |